Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · 4A
FDA Appropriations issues, including issues likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) V (currently unassigned) General FDA Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · fourth_quarter · Q4
Source: Senate LDA
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
Financial Services and General Government Appropriations Act, 2011
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Patent issues associated with anti-biotics (currently unassigned)
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
To amend the Small Business Act to provide for an increase in the amount of awards under the first and second phases of the Small Business Innovation Research program.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
Community-Based Mental Health Infrastructure Improvements Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
Community-Based Mental Health Infrastructure Improvements Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Patent issues associated with anti-biotics (currently unassigned)
Community-Based Mental Health Infrastructure Improvements Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Patent Reform and Intellectual Property issues, including issues surrounding patent settlements HR 3590, S 1796, and related bills and amendments - Follow-on biologics/pathway for biosimilar pharmaceuticals
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Prescription Drug Importation
America's Healthy Future Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Independent Drug Education and Outreach Act - Academic Detailing Issues Veterans Health Care Budget Reform and Transparency Act
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Physician Payments Sunshine Act of 2009
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Health Care Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Discuss Patient Assistance Programs Issues regarding disclosure of drug sample data Independent Drug Education and Outreach Act - Academic Detailing issues VA/DoD regarding TRICARE retail rebate legislation Veterans Health Care Budget Reform and Transparency Act Discussions regarding global access to medicines
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Patent Reform and Intellectual Property issues, including issues surrounding patent settlements HR 3590, S 1796, and related bills and amendments - Follow-on biologics/pathway for biosimilar pharmaceuticals
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
American Middle Class Tax (AMT) Relief Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
HR 3590, S 1796, and related bills and amendments - Prescription Drug Importation
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Physician Payments Sunshine Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Medicare Improvements for Patients and Providers Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Preserving Access to Medicare Act of 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Pulmonary and Cardiac Rehabilitation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Pulmonary and Cardiac Rehabilitation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Healthy Americans Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
American Samoa Possession Tax Credit Act of 2003
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Access to Life-Saving Medicine Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Protecting Consumer Access to Generic Drugs Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patient Protection and Innovative Biologic Medicines Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Food and Drug Administration Amendments Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
Food and Drug Administration Amendments Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Stem Cell Research Enhancement Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
Food and Drug Import Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Patent Reform Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries
340B Program Improvement and Integrity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
Children's Health Insurance Program Reauthorization Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Medicare Prescription Drug Price Negotiation Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Preserve Access to Affordable Generics Act
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
Stem Cell Research Enhancement Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
Mental Health Parity Act of 2007
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
To require cigarette products to be placed under or behind the counter in retail sales.
Client: ASTRAZENECA PHARMACEUTICALS LP · Firm: ASTRAZENECA PHARMACEUTICALS LP
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
FDA Appropriations issues, including issues likely to be incorporated into the Prescription Drug User Fee Act (PDUFA) V (currently unassigned) General FDA Issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · third_quarter · Q3
S. 3677, HR 4899 - legislative proposals surrounding patent reform and intellectual property issues, including patent settlements Patent issues associated with anti-biotics (currently unassigned)
FDA Appropriations issues, including issues likely to incorporated into the Prescription Drug User Fee Act (PDUFA) V (currently unassigned)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · second_quarter · 2A
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
FDA funding and appropriation issues (PDUFA V) (currently unassigned)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · second_quarter · Q2
FDA funding and appropriation issues (PDUFA V) (currently unassigned)
H.R.3590, S.1796 and related bills and amendments - legislative and regulatory proposals surrounding health care reform, including provisions regarding pharmaceutical pricing H.R. 4213 and related bills and amendments - proposals surrounding 340B program
H.R.3590, S.1796 and related bills and amendments - legislative proposals surrounding health care reform, including provisions regarding patent reform and intellectual property issues, including patent setttlements H.R.4899 and related bills and amendments - legislative proposals surrounding patent reform and intellectual property issues, including patent setttlements
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2010 · first_quarter · Q1
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding Prescription Drug Importation
HR. 3590, S 1796 and related bills and amendments - legislative proposals surrounding health care reform including provisions regarding pharmaceutical pricing and proposed revisions to 340B program FDA appropriations issues (currently unassigned)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · fourth_quarter · Q4
HR 3590, S 1796, and related bills and amendments - Prescription Drug Importation
HR 3590, S 1796, and related bills and amendments - Proposed revisions to 340B program HR 3590, S 1796, and related bills and amendments - Legislative proposals surrounding health care reform, including provisions regarding pharmaceutical pricing, insurance reform, and reimbursement issues
HR 3590, S 1796, and related bills and amendments - Patent Reform and Intellectual Property issues, including issues surrounding patent settlements HR 3590, S 1796, and related bills and amendments - Follow-on biologics/pathway for biosimilar pharmaceuticals
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · third_quarter · Q3
Health Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Independent Drug Education and Outreach Act - Academic Detailing Issues Veterans Health Care Budget Reform and Transparency Act
Prescription Drug Importation FDA Globalization Act of 2009
Patent settlements (reverse payments) legislation Patent reform and intellectual property issues Follow-on biologics legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · first_quarter · 1A
Medicaid - regarding possible increase in Medicaid base rebate; other issues regarding possible changes to Medicaid rebate program Comparative Effectiveness - regarding use of Comparative effectiveness in health care coverage and/or reimbursement Medicare - regarding "non-interfence" clause, protected classed of drugs, and Medicare Advantage
Direct-to-Consumer Drug Advertising Discussions regarding Funding of FDA
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · second_quarter · Q2
Funding of FDA FDA organizational issues - FDA reorganization into separate food and drug agencies Direct-to-consumer advertising
Health Care Reform S.301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Discuss Patient Assistance Programs Issues regarding disclosure of drug sample data Independent Drug Education and Outreach Act - Academic Detailing issues VA/DoD regarding TRICARE retail rebate legislation Veterans Health Care Budget Reform and Transparency Act Discussions regarding global access to medicines
Patent Reform and Intellectual Property Issues Patent settlements (reverse payments) legislation Follow-on biologics legislation
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2009 · first_quarter · Q1
Health Care Reform S. 301 Grassley/Kohl Physician Payments Sunshine Act of 2009 Mental Health Parity 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services VA/DoD Tricare - regarding TRICARE retail rebate legislation/rulemaking Discussions regarding global access to medicines Legislation or possible legislation regarind stem cell research Discussions regarding possible opportunities to work with CMS on education and outreach efforts
Prescription Drug Importation FDA Globalization Act of 2009-US House FDA preemption
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · third_quarter · 3A
Discussions regarding FDA Appropriations Discussions regarding e-Prescribing Discussions regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · fourth_quarter · Q4
S.558-The Mental Health Parity Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Health Care Reform:S.334-The Healthy Americans Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Cancer access and affordability issues, generally. No active legislation. Provision of information regarding company patient assistance programs. No active legislation. HIT 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Grassley/Kohn Physician Payments Sunshine Act Minority Outreach - Congressional Hispanic Caucus. No active legislation.
Regarding e-Prescribing Regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · third_quarter · Q3
S.558-The Mental Health Parity Act H.R. 1424-The Paul Wellstone Mental Health and Addiction Equity Act Health Care Reform:S.334-The Healthy Americans Act Cancer access and affordability issues, generally. No active legislation. Grassley/Kohl Physician Payments Sunshine Act Comparative Effectiveness Research - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services Minority Outreach - Congressional Hispanic Caucus. No active legislation Provision of information regarding company patient assistance programs. No active legislation
Discussions regarding FDA Appropriations Discussions regarding e-Prescribing Discussions regarding implementation of PDUFA IV/FDAAA Direct-to-Consumer Advertisement User Fee Program
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · second_quarter · Q2
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage S.2029 - Physician Payments Sunshine Act of 2007; Grassley/Kohl Bill - regarding proposal to require pharmaceutical manufacturers to disclose provision of items of value to physicians on an annual basis DoD Tricare issues, including retail pharmacy rebate and other issues Comparative Effectivensss - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement Genetic Information Nondiscrimination Act Information regarding company patient assistance program Health care reform Legislation to fund cancer research, cancer supportive services and improve access to coverage 340B program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
FDA appropriations Support of sufficient funding for the Food & Drug Administration to conduct meaningful and effective review of direct-to-consumer advertising
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · first_quarter · 1A
Support of sufficient funding for the Food & Drug Administration to conduct meaningful and effective review of Direct-to-Consumer advertising
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2008 · first_quarter · Q1
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate General discussion and increasing awareness of patient assistance program offerings Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and MedicareAdvantage H.R. 3162 - Children's Health and Medicare Protection Act of 2007 - regarding Medicare Physician Reimbursement Package, Medicare and Medicaid Drug Reimbursement
Support of sufficient funding for the Food & Drug Administration to conduct meaningful and effective review of Direct-to-Consumer advertising
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2007 · year_end · YY
S.1082 FDARA - reauthorization and funding of FDA and PDUFA-related issues HR 2900 FDAAA - reauthorization and funding of FDA and PDUFA-related issues HR 3610 Food & Drug Safety Act of 2007 - reauthorization and funding of FDA and PDUFA-related issues S. 1859/HR 3161 - Ag, Rural Dev, FDAdministration & Related Agencies Approp Act of 2008 - reauth and funding of FDA
Proposed increase in Medicaid Drug Rebate drug base rebate increase Proposed changes to Medicaid price reporting and requirements from earlier legislation (DRA) Medicare Part D formulary protection for six specified classes
ASTRAZENECA PHARMACEUTICALS LP via ASTRAZENECA PHARMACEUTICALS LP
2007 · mid_year · MM
S.5 & H.R. 3 - Stem Cell Research Enhancement Act of 2007
S.3 - Medicare Prescription Drug Price Negotiation Act of 2007 H.R. 4 - Medicare Prescription Drug Price Negotiation Act of 2007 Medicaid Rebate Rate
Drug Importation Issues S.A. 1010 - Safety and Cost Savings Certification re: Importation of Pharmaceuticals S. 242 & H.R.380 - Pharmaceutical Market Access and Drug Safety Act of 2007 Safe Drug Compounding Act of 2007 (draft legislation - no bill number)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Patent Reform and intellectual property issues Section 182 ("Special 301") briefings on global intellectual property protections Discussions regarding patent settlements (reverse payments) legislation Discussions regarding follow on biologics
Prescription Drug Importation FDA Globalization Act of 2009-US House FDA preemption
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Proposals regarding Medicaid rebates and subsidy issues Proposals regarding changes to Medicare Part D, including changes as part of health care reform initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Direct-to-Consumer Drug Advertising Discussions regarding Funding of FDA
Patent Reform and intellectual property issues Section 182 ("Special 301") briefings on global intellectual property protections Discussions regarding patent settlements (reverse payments) legislation Discussions regarding follow on biologics
Medicaid - regarding possible increase in Medicaid base rebate; other issues regarding possible changes to Medicaid rebate program Comparative Effectiveness - regarding use of Comparative effectiveness in health care coverage and/or reimbursement Medicare - regarding "non-interfence" clause, protected classed of drugs, and Medicare Advantage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR)
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Medicaid Base Rebate Increase-US House Medicare:S.3101/H.R. 6331-The Medicare Improvements for Patients & Providers Act; S.3118-The Preserving Access to Medicare Act; Deficit Reduction Act-US Senate Waxman proposal for Medicaid-type rebates for dual eligibles enrolled in Medicare Part D. No active legislation-US House Discussions regarding retaining private market price negotiations between manufacturers and Medicare Part D plans -US Senate Discucssions with the Office of Provider Relations, CMS Discussions regarding maintenance of six protected classes of pharmaceutical products under Medicare Part D
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate Issues arising from Deficit Reduction Act Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage S.3101 & H.R. 6331 - The Medicare Improvements for Patients & Providers Act S.3118 - The Preserving Access to Medicare Act Legislation to address physician payment issues, including SGR, and related provisions to Medicare package
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Discussions and possible legislation regarding possible increase in Medicaid program base rebate rate General discussion and increasing awareness of patient assistance program offerings Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and MedicareAdvantage
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
S.558 & H.R. 1424 - The Mental Health Parity Act of 2007 - regarding requirement for health plans and employers to provide mental health insurance coverage comparable to that of traditional medical coverage Physician Payments Transparency - Grassley/Kohl Bill - regarding proposal to require pharmaceuctical manufacturers to disclose provision of items of value to physicians on an annual basis Legislation to fund cancer research, cancer supportive services, and improve access to coverage S.329 Pulmonary and Cardiac Rehabilitation Act of 2007 - regarding possible amendments to Title XVIII of SSA to provide coverage of items and services under cardiac or pulmonary rehabilitation programs Comparative Effectiveness - Senate proposal regarding use of comparative effectiveness in health care coverage and/or reimbursement 340B Program - regarding legislation that would require extension of 340B pricing to pharmacies who also serve patients who do not qualify for 340B services
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Renewal of Research and Development Tax Credit within context of proposed changes to Alternative Minimum Tax
S.1145/1908 The Patent Reform Act of 2007 - Potential implications on pharmaceutical patent protection, including reform to address current inefficiencies that do not harm innovative industries
Patient safety from the commercial importation of prescription medications Manufacturer outsourcing of active pharmaceutical ingredients to certain countries
Illegal compounding of commercially available pharmaceuticals by pharmacists
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
S.1082-Food and Drug Administration Revitalization Act of 2007 H.R. 2900 Food and Drug Administration Amendments Act of 2007 Illegal Pharmaceutical Manufacturing S.1859 Agriculture Appropriations - Title VI: Food and Drug Administration
S. 316 & H.R. 1432 - Preserve Access to Affordable Generics Act H.R. 1902 - Protecting Access to Generic Drugs Act of 2007 H.R. 1908-Patent Reform Act of 2007 H.R. 1038-Access to Life-Saving Medicine Act - Follow-on Biologics H.R. 1956-Patient Protection and Innovative Biologic Medicines Act of 2007 S.1145-Patent Reform Act of 2007
H.R. 1424 The Paul Wellstone Mental Health and Addiction Equity Act of 2007 S. 1893-Children's Health Insurance Program Reauthorization Act H.R. 3162-Children's Health Insurance Program Reauthorization Act S.558-The Mental Health Parity Act of 2007 S. 1376 - 340B Program Improvement and Integrity Act of 2007
Filing targets: HOUSE OF REPRESENTATIVES, SENATE